Astellas Pharma Inc.

FDA inspection history in Takaoka, Japan, 2019 to 2025

2
Form 483s

Every document, by year

  • Form 483

2019: one Form 483; 2025: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2019One Form 483, at Takaoka, Japan.
  2. 2019The longest 483 on file: 8 observations over 8 pages at Takaoka, Japan.
  3. 2025One Form 483, at Takaoka, Japan.

Cited most

Across all Astellas Pharma observations on file

The complete Astellas Pharma file.

All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$198

The price of the documents, added to your cart together

Sites

Documents

2 on file, newest first
DateDocumentPrice
2025-06-06483 Form 483$99
2019-03-05483 Form 483$99

Investigators on these documents

Bijoy Panicker (1)Jose A. Cruz-Gonzalez (1)

FEI number 3002807001 · most recent document Jun 6, 2025

About Astellas Pharma Inc.

How many FDA Form 483s has Astellas Pharma Inc. received?

FDA Intel has 2 Form 483s on file for Astellas Pharma Inc.; the most recent is dated Jun 6, 2025.

When was Astellas Pharma Inc. last inspected by FDA?

The most recent FDA inspection document on file for Astellas Pharma Inc. is a Form 483 dated Jun 6, 2025, for the site in Takaoka, Japan.

What did FDA cite at Astellas Pharma Inc.?

The regulations cited most in the observations on file for Astellas Pharma Inc. are 21 CFR 211.110(a) (Sampling and testing of in-process materials and drug products), 2 times; 21 CFR 211.113(b) (Control of microbiological contamination), 2 times; 21 CFR 211.100(a) (Written procedures; deviations), 1 time.